Smooth muscle proliferation is a prominent feature of the vascular response to mechanical injury. Accordingly, modulation of proliferation has important therapeutic implications for angioplasty restenosis. We have identified a subclass of thiol protease inhibitors (TPIs) that reversibly inhibit bovine aortic smooth muscle cell (BASMC) proliferation in vitro. To define the nature of this inhibition, an evaluation of selected steps in the cell cycle was undertaken. Treatment of BASMCs with benzyloxycarbonylLeu-norleucinal (calpeptin) at 100 ,uM and acetyl-Leu-Leu-norleucinal (TPI-1) at 50 gtM was shown to cause a block of platelet-derived growth factor-BB as well as serum-inducible cell cycle progression at a point before the G1-S boundary, reducing the percentage of bromodeoxyuridine-positive cells from 87% to 5% over a 24-hour labeling period. Addition of TPI-1 at various times after serum addition to serum-deprived BASMCs showed 80%1 of the maximal block of DNA synthesis even when added 6 hours after serum. The cell cycle progression block was gradually lost as the delay from serum to TPI-1 application was increased from 6 to 12 hours. By Northern analysis of mRNA after serum addition, TPI-1 caused a fourfold decrease in the transient elevation offos and myc proto-oncogene as well as a decrease in the levels of both muscle and nonmuscle actin mRNA induced early after serum addition. Flow cytometric analysis of DNA content and synthesis in BASMCs treated with TPI-1 or calpeptin additionally revealed the presence of a distinct cell cycle block in the G2-M compartment. In the aggregate, these results suggest the existence of more than one molecular site potentially involved in inhibition by TPI of cell cycling in BASMCs. (Circulation Research 1993;72:413-423) KEY WoRDs * smooth muscle * protease inhibitors * cellular proliferation P roteases catalyze many key reactions underlying both normal and pathological processes. Blood coagulation, fibrinolysis, complement activation, and protein catabolism are a few of the more wellknown examples of protease-dependent processes.' In addition, proteases play an important role in cellular growth and proliferation. In some cases, this role is obvious or clearly defined. For example, the cell cycledependent protein cyclin is rapidly degraded at the end of metaphase and beginning of anaphase in dividing cells.2 In addition, extracellular (i.e., collagenase, stromelysin, and elastase) and membrane-bound proteases are activated to digest the extracellular matrix or selected proteins that connect cells to this matrix, facilitating the migration and spread of both normal and tumor cells.3-5 The lysosomal thiol protease cathepsin L is induced and secreted by fibroblasts in response to malignant transformation, growth factors, and tumor promoters.6 Moreover, antisense RNA-induced reduction in the levels of the tissue inhibitor of metalloenFrom the
P roteases catalyze many key reactions underlying both normal and pathological processes. Blood coagulation, fibrinolysis, complement activation, and protein catabolism are a few of the more wellknown examples of protease-dependent processes.' In addition, proteases play an important role in cellular growth and proliferation. In some cases, this role is obvious or clearly defined. For example, the cell cycledependent protein cyclin is rapidly degraded at the end of metaphase and beginning of anaphase in dividing cells.2 In addition, extracellular (i.e., collagenase, stromelysin, and elastase) and membrane-bound proteases are activated to digest the extracellular matrix or selected proteins that connect cells to this matrix, facilitating the migration and spread of both normal and tumor cells. [3] [4] [5] The lysosomal thiol protease cathepsin L is induced and secreted by fibroblasts in response to malignant transformation, growth factors, and tumor promoters.6 Moreover, antisense RNA-induced reduction in the levels of the tissue inhibitor of metalloen-doproteases in fibroblasts confers on these cells enhanced invasiveness and tumorigenicity.7 Furthermore, balloon injury to the rat carotid artery, which induces proliferation and migratory movements of vascular smooth muscle cells, is associated with the expression of two serine proteases, urokinase and tissue-type plasminogen activator. 8 Further evidence for the role of proteases in cellular growth, differentiation, and proliferation has been inferred from the action of various naturally occurring and synthetic protease inhibitors; e.g., cystatin, a thiol protease inhibitor found in serum, can greatly enhance the proliferative activity of fibroblasts in culture. 9 Other more lipid-soluble thiol protease inhibitors (TPIs) have been shown to enhance proliferation at low concentrations but inhibit at higher levels. 10 The oligopeptide aldehyde TPI, antipain, has been shown to reduce c-myc expression without altering proliferation, RNA synthesis, or saturation density in C3H 10T 1/2 cells." With regard to differentiation, leupeptin and related TPI analogues have been shown to enhance neurite outgrowth (e.g., a feature of maturity) in PC12h cells.'2 In addition, metalloendoprotease inhibitors can prevent differentiation of L6 myoblasts. 13 Another interesting link between growth mechanisms and the thiol proteases can be found in the products of the ras family of proto-oncogenes. For example, ras oncogene products share amino acid sequence homology with TPIs such as the cystatins and kininogens.10,14
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-NH ---CH ---c 24 28 described in the figure legends. At the end of the incubation, cells were released from the wells, and the unincorporated precursor was removed by washing with distilled water cell residues collected on glass mesh filter by an automated cell harvester. Radioactivity was measured by liquid scintillation spectroscopy.
Flow Cytometric Assays Cells were plated, allowed to attach, and placed in serum-free medium for 48-52 hours as described above.
Compounds to be tested were added at the designated concentrations in the serum-free medium followed by serum-containing medium, also as described above. At the specified times after serum addition, these cells were harvested by trypsin/EDTA, washed with Hanks' balanced salt solution/5% bovine serum albumin, pelleted, and resuspended in PBS. For single-color analysis, the PBS contained 0.6% Nonidet P-40 and 0. (Figure 1) . It is noted that the molecules appear widely distributed in hydrophobicity, with TPI-1, calpeptin, and TPI-2 relatively lipophilic, whereas E-64 and leupeptin are relatively hydrophilic. Although all are known to be potent TPIs in vitro,36,37 a range of inhibition of DNA synthesis was found, possibly related to variations in hydrophobicity and resulting variable accessibility to the intracellular site(s) of action. Benzyloxycarbonyl-Leu-norleucinal (calpeptin) and acetyl-Leu-Leu-norleucinal (TPI-1) were inhibitory to serum-stimulated DNA synthesis as measured by [3H]thymidine incorporation, with EC50 values of 56 and 14 ,M, respectively, whereas acetylLeu-Leu-methioninal (TPI-2) was not substantially inhibitory at concentrations up to 125 jiM (Figure 2 ).
Possible explanations for this may lie in its extremely hydrophobic nature (partition coefficient between octanol/water is 10-fold higher than TPI-1 or calpeptin; data not shown), a variation in enzyme specificity, or other features of metabolism or binding in cell culture. The hydrophilic inhibitors E-64 and leupeptin produced only small effects on thymidine incorporation ( Figure  3) . TPI-1 also demonstrated inhibition of PDGF-BBstimulated DNA synthesis with a somewhat lower EC50 of 3 ,uM (Figure 4) . Inhibition of DNA synthesis by TPI-1 could not be reversed by increasing the PDGF concentration to 50 ng/ml, well above the concentration (10 ng/ml) required to achieve maximum DNA synthe-FIGURE 9. Impact of chronic treatment with calpeptin (100 ,uM) and thiol protease inhibitor-i (50 (Figure 6 ). The majority of cycling cells were seen to progress through S phase during an interval from approximately 18-24 hours after serum repletion. Total RNA prepared from cells in serum deprivation and ½/2, 1, 2, and 4 hours after the addition of serum was probed for expression of actin, fos, myc, and APRT. Serum stimulation of this synchronized cell population caused transient elevation offos message level similar to that seen in alternative preparations.38,39 This was followed by a more gradual elevation in two RNA species annealing to the actin probe, one migrating with an estimated size of 2.1 kb, the length expected for nonmuscle ,B-actin message, and another migrating with an estimated size of 1.7 kb, consistent with a-actin message.
13-Actin induction occurs in response to proliferogenic stimuli in several cell types, including fibroblasts, whereas coinduction of a-actin has been described in mouse smooth muscle cells under certain culture conditions. 40 Nonzero baseline expression of c-myc was seen as described previously in bovine aortic smooth muscle cells,41 followed by an eightfold induction occurring subsequent to the c-fos induction. The transcript for the "housekeeping" gene, APRT, maintained a relatively invariant level during this time course ( Figure  7 , control lanes).
Single-color flow cytometry in populations synchronized by serum depletion as described above revealed an acute block of cell cycle progression occurring before a point near the Go/G,-S boundary, since essentially no increase in DNA content was seen in cells stimulated by serum in the presence of the active compounds TPI-1 or calpeptin (data shown for 100 ,uM calpeptin, Figure 8 ).
Flow cytometry similarly performed after addition of these inhibitors to unsynchronized populations showed a marked increase in cells with 4n DNA content within 24 hours and subsequent additional accumulation of cells in this compartment over an additional 24 hours, sustained during prolonged incubation ( Figure 9 ). This suggests an additional block of cell cycle progression in the G2 phase with some release of cells from the initial block before S phase. On removal of these inhibitors after this block, cells continued to cycle as a diploid population.
Two-color flow cytometry was performed using propidium iodide and fluorescein-labeled anti-BrdU to allow concomitant evaluation of total DNA content and DNA synthesis occurring in synchronized cells after serum stimulation during BrdU incubation.34 Minimal incorporation of BrdU was seen at 21 and 24 hours after serum addition in the presence of either TPI-1 or calpeptin (Figure 10) , thus confirming the location of the block as pre-S phase. Further definition of the inhibitor-sensitive point of the cell cycle was obtained by experiments in which the time of TPI-1 exposure was varied relative to the time of serum stimulation. It was found that complete inhibition of DNA synthesis and S-phase entry was maintained without the necessity for pretreatment with TPI-1 before serum addition. Moreover, inhibition of S-phase entry was seen with addition of TPI-1 up to 6 hours after the addition of serum (approximately 10 hours before anticipated S-phase proportionally less effective as the onset of S phase was approached ( Figure 11 ). These data are complemented by study of the effect of TPI-1 on c-fos, c-myc, and actin induction by serum.
Northern analysis of total RNA from synchronized cells pretreated for 6 hours with TPI-1, in comparison with control cells, revealed reductions in peak fos and myc oncogene expression in response to serum of 75% and 80%, respectively, as well as a diminished level of both /3-and a-actin transcripts during the time of observation ( Figure 7 ). There appears to be some selectivity in effect as reflected in both a higher degree and duration of suppression seen with the a-actin transcript.
Discussion An important result of these findings is the observation that a single class of TPIs is active at three distinct locations in the cell cycle: the earliest part of the GO-G, transition, mid-G1-S, and the G2/M compartment. As such, these results represent the first description of pre-S-phase inhibitory activity of thiol protease inhibitors.
The inhibition of proto-oncogene expression in the early GO-G, transitional phase is apparently not a necessary prerequisite of the Gl-S block, based on the kinetic work described above. Multiple possible targets are thus implied for the antiproliferative effects of TPI-1. This bears interesting analogies to the recent recognition of the multiple antiproliferative effects of heparin on bovine aortic smooth muscle cells42 in which a late Gl-S block was described as well as a decrease in the c-fos and c-myc mRNA induction by serum, which was apparently not necessary for the later block.42 A similar effect of heparin on c-fos and c-myc was also observed in BALB/c 3T3 fibroblasts43 but not found by other investigators in smooth muscle cells44; this latter group did, however, describe a heparin-mediated decrease in the normally seen mid-to-late G1 peak of c-myb mRNA induced by serum. It has been suggested, based on studies with various mitogens including phorbol myristate acetate, that the observed heparin effects are related at least in part to effects on a protein kinase C-mediated pathway.
The reason for the gradual nature of the loss of DNA synthesis inhibition as the agents are added progressively later in G1 remains to be determined. Although this observation might result from a distribution of cell sensitivity to inhibition at a given point of the cell cycle several hours after serum addition, it may also represent a degree of asynchrony of cells progressing through the G1 phase after serum addition, such that a critical point for inhibition (at latest) before the onset of S phase has been passed by increasingly more cells as compound addition is progressively delayed. This issue could be addressed further in an independent fashion by experiments evaluating the time to onset of S phase after withdrawal of inhibition, as well as experiments evaluating the length of time for which cycling cells continue to enter S phase after inhibitor addition. 45 The increase of cells with 4n DNA content over time may be viewed as either representing a probability function for release of all cells or release of a limited number of resistant cells with time. In either case, the apparent block seen in the G2/M compartment is consistent with the earlier finding of metaphase arrest in epidermal carcinoma (A431) cells as well as primary and immortalized fibroblasts on incubation with the hydrophobic membrane-permeant TPI, E-64d, at =250 /M. 30 A role for calpain in progression through the M phase of the cell cycle has been supported by the observation of nuclear localization of calpain II 
